We’ll solve it. Together.
Bio-Rad has partnered with countless healthcare professionals, diagnostic laboratories, and researchers to help end the COVID-19 global pandemic. We offer both molecular and serology controls for monitoring your SARS-CoV-2 testing assay. The SARS-CoV-2, Flu, RSV Run Controls allow laboratories to evaluate day-to-day and lot-to-lot variation of their multiplexed molecular assay and to test for operator proficiency. Our serology controls are optimized for major total and IgG antibody and assay methodologies.
Our serology quality controls are optimized for major antibody assays and methodologies and are compatible with major infectious disease platforms. They offer recoveries close to cutoff for most major assays and instruments.
Our SARS-CoV-2 molecular standards can be used as reference material against five gene targets for research testing of the novel coronavirus. With these controls, you’ll be able to validate testing of the entire process of your molecular assay.
Our COVID-19 controls meet strict quality metrics and are manufactured according to the ISO 17511 requirement. This helps to ensure assay performance, reducing multiple troubleshooting steps.
A webinar with Elitza Theel, PhD, and Duane W. Newton, PhD, D (ABMM), FIDSA
SARS-CoV-2 has created significant challenges for laboratories, requiring the development, validation, and scale-up of testing in a very short time period.
Authors: Stephanie Mitchell, PhD, D(ABMM), et al.
Written on behalf of the American Society for Microbiology, article discusses the verification procedure of COVID tests for the detection of SARS-CoV-2 RNA.
Authors: Wei Zhen, et al.
Written for the Journal of Clinical Microbiology, this article compares the analytical sensitivity and clinical performance of four molecular in vitro diagnostic (IVD) COVID assays.
Some benefits for registering